PHARMA - Relationships

Word 1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 1 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Co-occurrence Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Occurence-Centile Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Correlation Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Overlap-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	G-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►
Psychiatric Disorder		Disease	Target	Cyclooxygenase-3
Obesity		Disease	Target	BRSK1
Carcinoma		Disease	Target	BRSK1
Carcinoma		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Hemorrhage		Disease	Drug	Apresoline (Hydralazine)- FDA
Acute Promyelocytic Leukemia		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Stroke		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Glomerulonephritis		Disease	Drug	Apresoline (Hydralazine)- FDA
Renal Failure		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Anemia		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
APOE		Target	Target	BRSK1
Cholesterol		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Collagen		Target	Drug	Ascorbic Acid (Vitamin C)- FDA
Hepatitis		Disease	Drug	Apresoline (Hydralazine)- FDA
Syphilis		Disease	Drug	Apresoline (Hydralazine)- FDA
Breast Cancer		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Lung Cancer		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
CD1A		Target	Target	AMAC-1
CD68		Target	Target	AMAC-1
CD68		Target	Target	Eotaxin-2/CCL24
Colon Cancer		Disease	Target	Complement Decay-Accelerating Factor
Skin Disease		Disease	Target	Eotaxin-2/CCL24
Lung Cancer		Disease	Drug	Kaad-Cyclopamine
Lung Cancer		Disease	Target	Kallikrein-8
Androgen Receptor		Target	Drug	Kaad-Cyclopamine
Non Small Cell Lung Cancer		Disease	Target	Kallikrein-8
Diabetes		Disease	Drug	Kaad-Cyclopamine
Diabetes		Disease	Target	464.1
Diabetes		Disease	Target	ALK Phos
Graft Versus Host Disease		Disease	Target	AMAC-1
CD4		Target	Target	Complement Decay-Accelerating Factor
CD4		Target	Target	AMAC-1
CCL7		Target	Target	Eotaxin-2/CCL24
744.1		Target	Target	464.1
Poisoning		Disease	Target	ALK Phos
Chronic Pain		Disease	Target	Mu-Type Opioid Receptor
Carcinoma		Disease	Target	464.1
Metastatic Breast Cancer		Disease	Drug	Aralen (Chloroquine)- FDA
Depression		Disease	Target	Mu-Type Opioid Receptor
Osteoarthritis		Disease	Target	ALK Phos
Osteoarthritis		Disease	Target	Kallikrein-8
Cancer		Disease	Target	ALK Phos
Cancer		Disease	Drug	Amitiza (Lubiprostone)- FDA
CCL4		Target	Target	Eotaxin-2/CCL24
Prostate Cancer		Disease	Target	464.1
Prostate Cancer		Disease	Target	ALK Phos
Prostate Cancer		Disease	Target	Kallikrein-8
Acute Promyelocytic Leukemia		Disease	Target	464.1
Tuberculosis		Disease	Target	Eotaxin-2/CCL24
Brain Cancer		Disease	Target	Kallikrein-8